Achieve Life Sciences, Inc. (ACHV) vs Candel Therapeutics, Inc. (CADL)
A side-by-side comparison of Achieve Life Sciences, Inc. and Candel Therapeutics, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
ACHV
Achieve Life Sciences, Inc.
$7.01HealthcareDelayed quote: Oct 5, 2026, 4:00 PM EDT
CADL
Candel Therapeutics, Inc.
$10.23HealthcareDelayed quote: Oct 5, 2026, 4:00 PM EDT
Total return — ACHV vs CADL
growth of $100 · dividends reinvested · last 5yACHV -9.9% (-2.1%/yr)CADL +46.1% (+7.9%/yr)CADL compounded faster over this window
ACHV CADL
ACHV vs CADL: by the numbers
- •CADL is the larger company ($750M vs $720M market cap).
Metrics side by side
Valuation
| Metric | ACHV | CADL |
|---|---|---|
| P/B ratio | N/A | 5.94 |
Profitability
| Metric | ACHV | CADL |
|---|---|---|
| Gross margin | 0.00% | 0.00% |
| Operating margin | 0.00% | 0.00% |
| Net margin | 0.00% | 0.00% |
| ROE | N/A | -70.19% |
| ROIC | N/A | -36.83% |
Growth (annualized)
| Metric | ACHV | CADL |
|---|---|---|
| Total return CAGR (5Y) | -4.33% | -1.42% |
Frequently asked
- How have ACHV and CADL total returns compared?
- Over the past 5 years, ACHV delivered -4.33% and CADL delivered -1.42% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.